Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.69 is 88% below its 5-year average of 13.75, near the low end of its 5-year range (1.69–33.98).
As of the fiscal period ended Tuesday, June 30, 2026. 66.96% below its 12-month average of 5.13.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.69.
QUICK RATIO (ACID-TEST)
1.69
QUICK RATIO (ACID-TEST) AVG TTM
5.13
QUICK RATIO (ACID-TEST) AVG 3Y
7.79
QUICK RATIO (ACID-TEST) AVG 5Y
13.75
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-66.96%
CURRENT VS 3Y AVG
-78.26%
CURRENT VS 5Y AVG
-87.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-49.51%
vs the sector median at left
Pulsenmore Ltd. Ordinary Shares
Market Cap
$14.05M
Quick Ratio (Acid-Test)
1.69
TTM Avg
5.13
3Y Avg
7.79
5Y Avg
13.75
Market Cap
$13.86M
Quick Ratio (Acid-Test)
1.60
TTM Avg
1.72
3Y Avg
1.47
5Y Avg
3.47
Market Cap
$13.75M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.46M
Quick Ratio (Acid-Test)
4.37
TTM Avg
1.21
3Y Avg
1.25
5Y Avg
1.53
Market Cap
$14.73M
Quick Ratio (Acid-Test)
0.76
TTM Avg
1.36
3Y Avg
2.82
5Y Avg
3.25
Market Cap
$13.30M
Quick Ratio (Acid-Test)
1.69
TTM Avg
0.14
3Y Avg
1.07
5Y Avg
2.78
Market Cap
$13.20M
Quick Ratio (Acid-Test)
0.40
TTM Avg
0.15
3Y Avg
4.02
5Y Avg
6.30
Market Cap
$14.94M
Quick Ratio (Acid-Test)
26.25
TTM Avg
8.96
3Y Avg
10.61
5Y Avg
33.19
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulsenmore Ltd. Ordinary Shares (PLSM) | $14.05M | 1.69 | 5.13 | 7.79 | 13.75 |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | 1.60 | 1.72 | 1.47 | 3.47 |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.75M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $14.46M | 4.37 | 1.21 | 1.25 | 1.53 |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | 0.76 | 1.36 | 2.82 | 3.25 |
| IN8bio, Inc. (INAB)vs › | $13.33M | 8.21 | 6.45 | 5.32 | 7.60 |
| Optimi Health Corp. (OPTH)vs › | $13.30M | 1.69 | 0.14 | 1.07 | 2.78 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | 0.40 | 0.15 | 4.02 | 6.30 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.94M | 26.25 | 8.96 | 10.61 | 33.19 |
| Passage Bio, Inc. (PASG)vs › | $13.11M | 1.22 | 3.07 | 6.03 | 8.35 |
Quick Ratio
1.69
Excludes inventory
Current Ratio
1.84
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.69 |
| 2025-12-31 | 7.24 |
| 2025-06-30 | 6.44 |
| 2024-12-31 | 7.65 |
| 2024-06-30 | 10.65 |
| 2023-12-31 | 9.99 |
| 2023-06-30 | 10.88 |
| 2022-12-31 | 12.52 |
| 2022-06-30 | 33.98 |
| 2021-12-31 | 23.67 |
| 2021-06-30 | 26.57 |
